MIV-247

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMIV-247
Drug Alias NameMIV-247
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin S inhibitors
TargetsCathepsin S
Therapy Area/IndicationsAutoimmune DiseasesNeuralgiaMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir AB
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeuralgiaMultiple Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A